Sierra Oncology Inc (SRRA) PT Raised to $38 at Oppenheimer, Following Clinical Business Update
Tweet Send to a Friend
Oppenheimer analyst Jay Olson raised the price target on Sierra Oncology Inc (NASDAQ: SRRA) to $38.00 (from $32.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
